Künstliche sauerstoffträger als alternative zur fremdbluttransfusion

Anaesthesist

Volumn 50, Issue SUPPL. 1, 2001, Pages

  Paxian, M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; FLUOROCARBON; OXYGEN;

BLOOD; BLOOD TRANSFUSION; HUMAN; INTRAOPERATIVE PERIOD; REVIEW;

BLOOD SUBSTITUTES; BLOOD TRANSFUSION; FLUOROCARBONS; HUMANS; INTRAOPERATIVE PERIOD; OXYGEN;

EID: 0344438187     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010170010     Document Type: Article

References (56)

1. Amberson WR, Jennings JJ, Rhode CR (1949) Clinical experience with hemoglobin-saline solutions. Appl Physiol 1: 469-89
2. Bunn HF (1971) Differences in the interaction of 2,3-Diphosphoglycerate with certain mammalian hemoglobins. Science 172: 1049-1050
3. Cernaianu AC, Spence RK, Vassilidze TV et al., (1994) Improvement in circulatory and oxygenation status by perflubron emulsion (oxygent HT) in a canine model of surgical hemodilution. Artif Cells Blood Substit Immobil Biotechnol 22: 965-977
4. Clark-LC J, Gollan F (1966) Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 152: 1755-1756
5. Cole DJ, Schell RM, Drummond JC et al., (1993) Focal cerebral ischemia in rats: effect of hemodilution with alpha-alpha cross-linked hemoglobin on brain injury and edema. Can J Neurol Sci 20: 30-36
6. Faithfull NS (1994) Mechanisms and efficacy of fluorochemical oxygen transportand delivery. Artif Cells Blood Substit Immobil Biotechnol 22: 181-197
7. Flaim SF (1994) Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes. Artif Cells Blood Substit Immobil Biotechnol 22: 1043-1054
8. Forman MB, Pitarys CJ, Vildibill HD et al., (1992) Pharmacologic perturbation of neutrophils by fluosol results in a sustained reduction in infarct size in the canine model of reperfusion. J Am Coll Cardiol 19: 205-216
9. Geyer RP, Monroe RG, Taylor K (1968) Survival of rats totally perfused with a perfluorocarbon-detergent preparation. In: Norman JV, Folkman J, Hardison LE, Ridolf LE, Veith FJ (eds) Organ Perfusion and Preservation. Appleton-Century-Crofts,New York, pp 85-95
10. Goodin TH, Grossbard EB, Kaufman RJ et al., (1994) A perfluorochemical emulsion for prehospital resuscitation of experimental hemorrhagic shock: a prospective, randomized, controlled study [see comments]. Crit Care Med 22: 680-689
11. Gould SA, Rosen AL, Sehgal LR et al., (1986) Fluosol-DA as a red-cell substitute in acute anemia. N Engl J Med 314: 1653-1656
12. Gould SA, Moore EE, Hoyt DB et al., (1998) The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery [see comments]. J Am Coll Surg 187: 113-120
13. Gulati A, Rebello S (1994) Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J Lab Clin Med 124: 125-133
14. Gulati A, Sen AP (1998) Dose-dependent effect of diaspirin cross-linked hemoglobin on regional blood circulation of severely hemorrhaged rats. Shock 9: 65-73
15. Habler OP, Kleen MS, Hutter JW et al., (1998) Hemodilution and intravenous perflubron emulsion as an alternative to blood transfusion: effects on tissue oxygenation during profound hemodilution in anesthetized dogs. Transfusion 38: 145-155
16. Hoffman SJ, Looker DL, Roehrich JM et al., (1990) Expression of fully functional tetrameric human hemoglobin in Escherichia coli. Proc Natl Acad Sci U S A 87: 8521-8525
17. Holman WL, Spruell RD, Ferguson ER et al., (1995) Tissue oxygenation with graded dissolved oxygen delivery during cardiopulmonary bypass. J Thorac Cardiovasc Surg 110: 774-785
18. Hughes-GS J, Antal EJ, Locker PK et al., (1996) Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med 24: 756-764
19. Jia L, Bonaventura C, Bonaventura J, Stamler JS (1996) S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control [see comments]. Nature 380: 221-226
20. Kasper SM, Grune F, Walter M et al., (1998) The effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 87: 284-291
21. Keipert PE, Gonzales A, Gomez CL et al., (1993) Acute changes in systemic blood pressure and urine output of conscious rats following exchange transfusion with diaspirin-crosslinked hemoglobin solution. Transfusion 33: 701-708
22. Keipert PE, Otto S, Flaim SF et al., (1994) Influence of perflubron emulsion particle size on blood half-life and febrile response in rats. Artif Cells Blood Substit Immobil Biotechnol 22: 1169-1174
23. Keipert PE, Faithfull NS, Bradley JD et al., (1994) Enhanced oxygen delivery by perflubron emulsion during acute hemodilution. Artif Cells Blood Substit Immobil Biotechnol 22: 1161-1167
24. Keipert PE, Faithfull NS, Roth DJ et al., (1996) Supporting tissue oxygenation during acute surgical bleeding using a perfluorochemical-based oxygen carrier. Adv Exp Med Biol 388: 603-609
25. Kent KM, Cleman MW, Cowley MJ et al., (1990) Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated fluosol. Am J Cardiol 66: 279-284
26. LaMuraglia GM, O'Hara PJ, Baker WH et al. (2000) The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. J Vasc Surg 31: 299-308
27. Lamy ML, Daily EK, Brichant JF et al., (2000) Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group [see comments]. Anesthesiology 92 [Suppl 3]: 646-656
28. Leese PT, Woodson RD, Shorr JS et al., (2000) Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers. Anesth Analg, in press
29. Macdonald VW, Winslow RM, Marini MA, Klinker MT (1990) Coronary vasoconstrictor activity of purified and modified human hemoglobin. Biomater Artif Cells Artif Organs 18: 263-282
30. Manning JE, Katz LM, Brownstein MR et al., (2000) Bovine hemoglobin-based oxygen carrier (HBOC-201) for resuscitation of uncontrolled, exsanguinating liver injury in swine. Carolina Resuscitation Research Group. Shock 13 [Suppl 2]: 152-159
31. Mitsuno T, Ohyanagi H, Naito R (1982) Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases. Ann Surg 195: 60-69
32. Nakai K, Matsuda N, Ohta T et al., (1994) Lysophosphatidylcholine, a component of stromal phospholipids, as a candidate vasoconstrictive factor in stroma-free hemoglobin. Artif Organs 18: 198-205
33. Novak L, Shackford SR, Bourguignon P et al., (1999) Comparison of standard and alternative prehospital resuscitation in uncontrolled hemorrhagic shock and head injury. J Trauma 47: 834-844
34. Noveck RJ, Shannon EJ, Leese PT et al., (2000) Randomized safety studies of intravenous perflubron emulsion. II. Effectson immune function in healthy volunteers. Anesth Analg, in press
35. Pelura TJ, Johnson CS, Tarara TE, Weers JG (1992) Stabilization of perflubron emulsions with egg yolk phospholipid. Biomater Artif Cells Immobil Biotechnol 20: 845-848
36. Postel M, Riess JG, Weers JG (1994) Fluorocarbon emulsions-the stability issue. Artif Cells Blood Substit Immobil Biotechnol 22: 991-1005
37. Rabiner SF, Helbert JR, Lopas H, Friedman LH (1967) Evaluation of a stroma-free hemoglobin solution for use as a plasma expander. J Exp Med 126: 1127-1142
38. Rabinovici R, Rudolph AS, Ligler FS et al., (1992) Biological responses to exchange transfusion with liposome-encapsulated hemoglobin. Circ Shock 37: 124-133
39. Riess JG (1992) Overview of progress in the fluorocarbon approach to in vivo oxygen delivery. Biomater Artif Cells Immobil Biotechnol 20: 183-202
40. Savitsky JP, Doczi J, Black J, Arnold JD (1978) A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 23: 73-80
41. Saxena R, Wijnhoud AD, Carton H et al., (1999) Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 30: 993-996
42. Schultz SC, Grady B, Cole F et al., (1993) A role forendothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 122: 301-308
43. Sherman IA, Dlugosz JA, Perelman V et al., (1993) Systemic hemodynamic and hepatic microvascular responses to a 33% blood volume exchange with whole blood, stroma-free hemoglobin, and oxypolyhemoglobin solutions. Biomater Artif Cells Immobil Biotechnol 21: 537-551
44. Siegel JH, Fabian M, Smith JA, Costantino D (1997) Use of recombinant hemoglobin solution in reversing lethal hemorrhagic hypovolemic oxygen debt shock. J Trauma 42: 199-212
45. Sloan EP, Koenigsberg M, Gens D et al., (1999) Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA 282: 1857-1864
46. Sloviter HA, Kamimoto T (1967) Erythrocyte substitute for perfusion of brain. Nature 216: 458-460
47. Smith DJ, Kornbrust ES, Lane TA (1994) Phagocytosis of a fluorescently labeled perflubron emulsion by a human monocyte cell line. Artif Cells Blood Substit Immobil Biotechnol 22: 1215-1221
48. Spahn DR, Brempt R van, Theilmeier G et al., (1999) Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group [see comments]. Anes thesiology 91: 1195-1208
49. Spence RK, McCoy S, Costabile J et al., (1990) Fluosol DA-20 in the treatment of severe anemia: randomized, controlled study of 46 patients. Crit Care Med 18: 1227-1230
50. Standl T, Wilhelm S, Horn EP et al., (1997) Akute hamodynamische Auswirkungen bei Patienten in der Leberchirurgie. Anaesthesist 46: 763-770
51. Urbaitis BK, Razynska A, Corteza Q et al., (1991) Intravascular retention and renal handling of purified natural and intramolecularly cross-linked hemoglobins. J Lab Clin Med 117: 115-121
52. Vlahakes GJ, Lee R, Jacobs-EE J et al., (1990) Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg 100: 379-388
53. Wahr JA, Trouwborst A, Spence RK et al., (1996) A pilot study of the effects of a perflubron emulsion, AF 0104, on mixed venous oxygen tension in anesthetized surgical patients. Anesth Analg 82: 103-107
54. Waschke K, Krieter H, Albrecht DM et al., (1993) Modifiziertes Hämoglobin als Blutersatzmittel im Rattenmodell. Anaesthesist 42: 90-95
55. Waschke KF, Riedel M, Albrecht DM et al., (1994) Effects of a perfluorocarbon emulsion on regional cerebral blood flow and metabolism after fluid resuscitation from hemorrhage in conscious rats. Anesth Analg 79: 874-882
56. Xu L, Sun L, Rollwagen FM et al., (1997) Cellular responses to surgical trauma, hemorrhage, and resuscitation with diaspirin cross-linked hemoglobin in rats. J Trauma 42: 32-41